Invivyd, Inc.是一家处于临床阶段的生物制药企业,专注于研发可预防和治疗严重病毒性传染病的广谱中和抗体疗法,核心管线覆盖呼吸道合胞病毒等高负担呼吸道病原体,满足全球患者未被满足的医疗需求。
GLUE
Monte Rosa Therapeutics, Inc.
营收
$12.8M
净利润
$-27.1M
KYMR
Kymera Therapeutics, Inc.
$11.5M
$-76.6M
IMVT
Immunovant, Inc.
$8.4M
$-75.3M
MLCI
Mount Logan Capital Inc.
$11.4M
$-13.4M
ACLX
Arcellx, Inc.
$8.1M
$-62.3M
RLAY
Relay Therapeutics, Inc.
$7.0M
N/A
CBNA
CHAIN BRIDGE BANCORP INC
$14.7M
$5.3M
TSHA
Taysha Gene Therapies, Inc.
$5.5M
$-27.9M